Dual Tasking Training to Build Self-Efficacy in Parkinson’s Disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study targets individuals with idiopathic Parkinson’s disease to see whether a structured dual tasking training program can boost self-efficacy. Participants engage in activities that combine motor and cognitive tasks to reflect real-life challenges. The goal is to determine if this approach improves functional independence, participation, and quality of life. The study requires participants at Hoehn and Yahr stages I–III with stable medication and the ability to walk independently. No information about control or randomization is provided in the available details.

Why it matters

Who can join: the full rules

Participants diagnosed with idiopathic Parkinson's disease confirmed by a neurologist will be recruited in this study. Inclusion criteria will be:

1. Hoehn \& Yahr stages I, II or III
2. Participants with no or mild to moderate neurocognitive impairments
3. Participants with and without symptoms of depression
4. Able to walk independently
5. Unaltered dose and type of medication up to three months before the commencement of the study
6. Participants able to understand and respond to the instructions given in the study.

Exclusion criteria will be:

1. The presence of any other concomitant neurological, musculoskeletal disease
2. History of leg or brain trauma or surgery
3. Vision or hearing problems that may affect the performance of cognitive tests
4. Clinical diagnosis of major neurocognitive disorder

Where it's running

• Facultad de Ciencias de la Rehabilitacion
  Santiago, Las Condes, Chile Recruiting

Study contacts

• Study coordinator: Rodrigo Araneda Director of Exercise and Rehabilitation Sciences Institute, PhD
• Email: rodrigo.araneda@unab.cl
• Phone: +56226618608

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ginger as a Modifier of Ghrelin Levels in Parkinson’s Disease and REM Sleep Behavior Disorder

  This study tests whether ginger capsules can raise ghrelin levels in people with Parkinson’s disease, REM sleep behavior disorder, and healthy controls.

  Recruiting Cambridge University Hospitals NHS Foundation Trust · Cambridge · NCT07882108

• Intraoperative Microelectrode Recordings with MAVEN vs Standard Equipment

  This study tests whether MAVEN can match the recording data collected during DBS surgery for movement disorders using standard equipment.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07868614

• Mental imagery with self-regulation to help daily activities in Parkinson's disease

  This study tests whether a six-week program of mental imagery combined with self-regulation can help people with Parkinson’s perform daily activities better than standard learning or exercise.

  Recruiting The Hong Kong Polytechnic University · Hong Kong · NCT07860294

• Real-world experiences of Inbrija for Parkinson's OFF episodes

  This study looks at how people with Parkinson’s who use Inbrija for OFF episodes feel and function in daily life.

  Recruiting Merz Pharmaceuticals GmbH · Altmünster and 1 other locations · NCT07797790

• Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns

  This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.

  Recruiting University of Cambridge · Cambridge, CB2 · NCT07786116

• Test of RO7568282 in early Parkinson's disease

  This study tests whether RO7568282, compared with placebo, is safe and helps people with early Parkinson's disease who are already taking levodopa.

  Recruiting at 4 sites Phase 2 Hoffmann-La Roche · Boca Raton, Florida and 3 other locations · NCT07781644

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.